Insights & Resources

The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.

The biopharma industry has experienced a resurgence the first part of 2024. J.P. Morgan’s Q2 report shares critical insights into the future of the industry.

Unravel life sciences industry complexities, and discover the differences between FDA special review designations like Fast Track, Priority Review and Breakthrough.

The credit is aimed at bolstering and incentivizing the emerging biotechnology sector to create jobs and invest in NYC and is available 1/1/23-1/1/26.

Change Healthcare was impacted by a cybersecurity incident that breached its information technology network.

In a business sale, due diligence is critical to mitigate the risk of unexpected tax issues for buyers and sellers. Find out key components of tax due diligence.

A summary of changes to R&E expenditure tax treatment in the proposed Tax Relief for American Families and Workers Act of 2024.

Administrative, physical, and technical safeguards are an essential element of HIPAA security and essential for protecting PHI and ePHI.

HIPAA’s requirements apply to more than doctors and hospitals. Protect your business and clients by learning about key requirements including who needs to comply.

Non-medical businesses may be surprised that they are subject to HIPAA because they have clients handling ePHI.

The Internal Revenue Service released interim guidance to clarify the application of IRC Section 174 after the amendments made by the Tax Cuts and Jobs Act (TCJA).